BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21482366)

  • 1. Update on management of ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chao KH; Lien YR; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):2-10. PubMed ID: 21482366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ovarian hyperstimulation syndrome].
    Le Gouez A; Naudin B; Grynberg M; Mercier FJ
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):353-62. PubMed ID: 21398079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ovarian hyperstimulation syndrome--diagnostic criteria, management procedures].
    Jakimiuk AJ; Grzybowski W; Zakrzewski J; Lewandowski P; Kozioł K
    Ginekol Pol; 2006 Nov; 77(11):885-92. PubMed ID: 17378130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on ovarian hyperstimulation syndrome].
    Delbaere A; Rodesch C; Englert Y
    Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
    Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian hyperstimulation syndrome--prevention and treatment].
    Grønlund LA; Bogstad JW
    Ugeskr Laeger; 1996 Dec; 158(50):7205-9. PubMed ID: 9012033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis.
    Binder H; Dittrich R; Einhaus F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(1):11-26. PubMed ID: 17987884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian hyperstimulation syndrome in medically assisted reproduction].
    Rogé P; Erny R
    Rev Fr Gynecol Obstet; 1994 Oct; 89(10):495-501. PubMed ID: 7817078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation syndrome: facts and fallacies.
    Beerendonk CC; van Dop PA; Braat DD; Merkus JM
    Obstet Gynecol Surv; 1998 Jul; 53(7):439-49. PubMed ID: 9662730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of ovarian hyperstimulation syndrome.
    Vlahos NF; Gregoriou O
    Ann N Y Acad Sci; 2006 Dec; 1092():247-64. PubMed ID: 17308149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive care treatment of ovarian hyperstimulation syndrome (OHSS).
    Sansone P; Aurilio C; Pace MC; Esposito R; Passavanti MB; Pota V; Pace L; Pezzullo MG; Bulletti C; Palagiano A
    Ann N Y Acad Sci; 2011 Mar; 1221():109-18. PubMed ID: 21401638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
    Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
    Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of ovarian hyperstimulation syndrome.
    Dourron NE; Williams DB
    Semin Reprod Endocrinol; 1996 Nov; 14(4):355-65. PubMed ID: 8988530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in mechanisms for development of ovarian hyperstimulation syndrome.
    Kasum M
    Coll Antropol; 2010 Sep; 34(3):1139-43. PubMed ID: 20977119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y; Barak V; Nisman B; Schenker JG
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin].
    Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A
    Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.